Clarisse Lobo

2.1k citations
24 papers · 1.5k indexed · 1 hit paper · h-index 12
Topics
Hemoglobinopathies and Related Disorders (14 papers)Iron Metabolism and Disorders (11 papers)Chronic Myeloid Leukemia Treatments (6 papers)
Journals
New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations
BrazilUnited StatesItaly

In The Last Decade

Clarisse Lobo

22 papers receiving 1.5k citations

Hit Papers

Nilotinib versus Imatinib for Newly Diagnosed Chronic Mye...201020262015202020102505007501000

Peers

Clarisse Lobo
Comparison fields: 5 of 75
  • Hematology 1.3k
  • Genetics 1.1k
  • Rheumatology 647
  • Oncology 195
  • Public Health, Environmental and Occupational Health 145
Replace P. Le Coutre with:
P. Le Coutre Germany
Carolina Pavlovsky Argentina
Lydia Wunderle Germany
Juan Luis Steegmann Spain
François-Xavier Mahon France
Philippe Rousselot France
Agnès Guerci‐Bresler France
Agnès Guerci France
S G O'Brien United Kingdom
Kasia Kozlowski United Kingdom
Clarisse Lobo relative to P. Le Coutre Germany P. Le Coutre's profile →
Citations per field
00.5×1.5×
P. Le Coutre · 1×
Citations per year

Countries citing papers authored by Clarisse Lobo

Since Specialization
Citations

This map shows the geographic impact of Clarisse Lobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarisse Lobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarisse Lobo more than expected).

Fields of papers citing papers by Clarisse Lobo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clarisse Lobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarisse Lobo. The network helps show where Clarisse Lobo may publish in the future.

Co-authorship network of co-authors of Clarisse Lobo

This figure shows the co-authorship network connecting the top 25 collaborators of Clarisse Lobo. A scholar is included among the top collaborators of Clarisse Lobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clarisse Lobo. Clarisse Lobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 11
5 37
6 12
7 19
8 43
9 1
10 12
11 9
12
Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemiabreakdown →
1182
13 7
14 37
15 15
16 28
17 6
18 4
19 22
20
[Menetrier disease associated with ulcerative colitis. Response to the treatment with octreotide. Review of the diagnostic criteria and etiopathogenesis].
6

About Clarisse Lobo

Clarisse Lobo is a scholar working on Genetics, Hematology and Rheumatology, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (14 papers), Iron Metabolism and Disorders (11 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (1.1k citations) and Rheumatology (647 citations). Clarisse Lobo has collaborated with scholars based in Brazil, United States and Italy. Frequent co-authors include Timothy P. Hughes, Andreas Hochhaus, Giuseppe Saglio, Richard A. Larson, Hagop M. Kantarjian, Ricardo Pasqüini, Richard E. Clark, Neil J. Gallagher, Md Ariful Haque and Albert Hoenekopp. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026